Drug Profile
Fidarestat
Alternative Names: Aldos; SK 860; SNK 860Latest Information Update: 07 Apr 2006
Price :
$50
*
At a glance
- Originator Sanwa Kagaku Kenkyusho
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Phase Unknown Diabetic neuropathies
Most Recent Events
- 07 Apr 2006 Discontinued - Phase-II/III for Diabetic neuropathies in Europe (PO)
- 07 Apr 2006 Discontinued - Phase-II/III for Diabetic neuropathies in USA (PO)
- 03 Apr 2006 Daiichi Pharmaceutical has merged with Sankyo to form Daiichi Sankyo Inc